Overview
Precision oncology uses next-generation sequencing (NGS) of the tumour to find the specific mutations driving each cancer — then matches the patient to targeted therapies, immunotherapy or clinical trials designed for that mutation.
Dr. Ravi Jaiswal orders and interprets comprehensive genomic profiling for lung, breast, colon, ovarian, pancreatic and rare cancers, and presents complex cases at molecular tumour boards to select the best option.
How we treat it
- Comprehensive genomic profiling (NGS panels)
- Liquid biopsy (circulating tumour DNA) testing
- Homologous recombination deficiency (HRD) testing
- Molecular tumour board case review
- Access to targeted therapies and trial pathways
Frequently asked questions
Is precision oncology only for advanced cancer?+
It is most impactful in advanced or rare cancers, but molecular testing is now standard even in early-stage lung, breast and colon cancer to guide treatment.
Is NGS testing covered by insurance?+
Coverage is improving. We help patients navigate reimbursement and choose the most cost-effective panel for their situation.
This page is for information only and does not replace a medical consultation. Please speak to a qualified doctor for advice specific to your condition.